Certa

Culture & Overview

Certa.ai has been recognized as a Leader in the Gartner® Magic Quadrant™ for Third-Party Risk Management Tools in April 2026. The company has also launched new initiatives, including OS3 and next-generation AI agents, to enhance third party risk and compliance management. Additionally, Certa Specialty Limited was launched in August in collaboration with Markel International and Certa Insurance Partners, focusing on consultancy services for managing agents and Coverholders in the Lloyd's London market. - ## Recent posts - 2026-04-08: We are extremely excited to share that Certa has been named a Leader in the first Gartner® Magic Quadrant™ for Third-Party Risk Management Tools. Get your complimentary access here: As Gartner notes, “Leaders combine advanced capabilities, such as AI-native risk detection and continuous monitor... - 2026-04-14: Nine years ago, we saw what TPRM needed to become. Last w - Press Releases Trustpair and Certa Partner to Deliver Best-in-Class Vendor Fraud Prevention and Compliance for Procurement Leaders June 8, 2026 Press Releases Why Third Party Risk Is Now A Board-Level Problem May 18, 2026 Press Coverage TPRA and Industry Leaders Unite to Launch the Standard Trust Portal Guidance May 4, 2026 Press Releases Certa Earns Top Tech and Customer Value Distinctions in Ris - company itself has seen recent expansion. In August , Certa Specialty Limited was launched in collaboration with Markel International and Certa Insurance Partners. The new unit, led by Dan Lott, provides consultancy services for managing agents and Coverholders in the Lloyd's London market, focusing on binding authority agreements, capacity deployment, and governance. Certa Insurance Partners also - | | | --- | | Application Date | 7/18/2023 | | Grant Date | 2/20/2024 | | Title | Solid forms, salts and polymorphs of anti-fibrotic compounds | | Related Topics | Kidney diseases, Transcription factors, Rare diseases, Diabetes, Nephrology | | Status | Grant | ## LatestCerta Therapeutics News 強皮症パイプライン分析2026（臨床試験フェーズ別、医薬品種類別）グローバル市場調査レポートを発表 Sep 2, 2026 [...] Technology Vendors Recent Research New